Investment Analysts’ Upgrades for December 13th (AKBA, AMPL, CAH, CCS, CIEN, CNC, CRM, DHR, FRBA, GIS)

Investment Analysts’ upgrades for Friday, December 13th:

Akebia Therapeutics (NASDAQ:AKBA) was upgraded by analysts at StockNews.com from a sell rating to a hold rating.

Amplitude (NASDAQ:AMPL) was upgraded by analysts at KeyCorp from a sector weight rating to an overweight rating. They currently have $15.00 target price on the stock.

Cardinal Health (NYSE:CAH) was upgraded by analysts at Wells Fargo & Company from an underweight rating to an equal weight rating. They currently have $127.00 target price on the stock, up from their previous target price of $101.00.

Century Communities (NYSE:CCS) was upgraded by analysts at JPMorgan Chase & Co. from an underweight rating to a neutral rating. JPMorgan Chase & Co. currently has $97.00 target price on the stock, down from their previous target price of $110.00.

Ciena (NYSE:CIEN) was upgraded by analysts at Bank of America Co. from a neutral rating to a buy rating. They currently have $95.00 target price on the stock, up from their previous target price of $70.00.

Centene (NYSE:CNC) was upgraded by analysts at UBS Group AG from a neutral rating to a buy rating. UBS Group AG currently has $80.00 target price on the stock, up from their previous target price of $79.00.

Salesforce (NYSE:CRM) was upgraded by analysts at KeyCorp from a sector weight rating to an overweight rating. They currently have $440.00 target price on the stock.

Danaher (NYSE:DHR) was upgraded by analysts at Bank of America Co. from a neutral rating to a buy rating. Bank of America Co. currently has $290.00 target price on the stock.

First Bank (NASDAQ:FRBA) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.

General Mills (NYSE:GIS) was upgraded by analysts at Bank of America Co. from a neutral rating to a buy rating. They currently have $80.00 target price on the stock, up from their previous target price of $78.00.

Gaming and Leisure Properties (NASDAQ:GLPI) was upgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an overweight rating. JPMorgan Chase & Co. currently has $54.00 target price on the stock, up from their previous target price of $49.00.

Vail Resorts (NYSE:MTN) was upgraded by analysts at StockNews.com from a sell rating to a hold rating.

Norwegian Cruise Line (NYSE:NCLH) was upgraded by analysts at Barclays PLC from an equal weight rating to an overweight rating. The firm currently has $32.00 price target on the stock, up from their previous price target of $28.00.

PENN Entertainment (NASDAQ:PENN) was upgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an overweight rating. The firm currently has $27.00 price target on the stock, up from their previous price target of $19.00.

PTC Therapeutics (NASDAQ:PTCT) was upgraded by analysts at Morgan Stanley from an equal weight rating to an overweight rating. They currently have $67.00 target price on the stock, up from their previous target price of $45.00.

Patterson-UTI Energy (NASDAQ:PTEN) was upgraded by analysts at The Goldman Sachs Group, Inc. from a neutral rating to a buy rating. The firm currently has $10.00 price target on the stock, down from their previous price target of $11.00.

PayPal (NASDAQ:PYPL) was upgraded by analysts at Wolfe Research from a peer perform rating to an outperform rating. The firm currently has $107.00 price target on the stock.

Robert Half (NYSE:RHI) was upgraded by analysts at Truist Financial Co. from a hold rating to a buy rating. The firm currently has $90.00 target price on the stock, up from their previous target price of $62.00.

Gibraltar Industries (NASDAQ:ROCK) was upgraded by analysts at StockNews.com from a buy rating to a strong-buy rating.

Revvity (NYSE:RVTY) was upgraded by analysts at Bank of America Co. from a neutral rating to a buy rating. They currently have $138.00 target price on the stock.

Sangamo Therapeutics (NASDAQ:SGMO) was upgraded by analysts at Truist Financial Co. from a hold rating to a buy rating. They currently have $7.00 target price on the stock.

Block (NYSE:SQ) was upgraded by analysts at Monness Crespi & Hardt from a neutral rating to a buy rating. They currently have $115.00 target price on the stock.

Sempra (NYSE:SRE) was upgraded by analysts at Morgan Stanley from an equal weight rating to an overweight rating. They currently have $98.00 target price on the stock, up from their previous target price of $85.00.

TaskUs (NASDAQ:TASK) was upgraded by analysts at Morgan Stanley from an equal weight rating to an overweight rating. The firm currently has $21.00 target price on the stock, up from their previous target price of $18.00.

Upstart (NASDAQ:UPST) was upgraded by analysts at Needham & Company LLC from a hold rating to a buy rating. Needham & Company LLC currently has $100.00 target price on the stock.

Marriott Vacations Worldwide (NYSE:VAC) was upgraded by analysts at Barclays PLC from an equal weight rating to an overweight rating. They currently have $116.00 target price on the stock, up from their previous target price of $97.00.

Viper Energy (NASDAQ:VNOM) was upgraded by analysts at KeyCorp from a sector weight rating to an overweight rating. The firm currently has $62.00 price target on the stock.

Receive News & Ratings for Akebia Therapeutics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akebia Therapeutics Inc and related companies with MarketBeat.com's FREE daily email newsletter.